Madhuravasal Krishnan J, Kong L, Meeds H, Roskin K, Medvedovic M, Sherman K
PLoS One. 2025; 20(2):e0298341.
PMID: 40014575
PMC: 11867328.
DOI: 10.1371/journal.pone.0298341.
Aluthge N, Adams S, Davila C, Gocchi Carrasco N, Chiou K, Abadie R
Front Microbiol. 2024; 15:1470037.
PMID: 39697649
PMC: 11652967.
DOI: 10.3389/fmicb.2024.1470037.
Tarfa A, Lier A, Shenoi S, Springer S
Expert Rev Clin Pharmacol. 2024; 17(7):549-564.
PMID: 38946101
PMC: 11299801.
DOI: 10.1080/17512433.2024.2375448.
Hill K, Thakarar K, Eslinger H, Prosperino L, Sue K
Public Health Rep. 2023; 138(6):862-864.
PMID: 37610106
PMC: 10576482.
DOI: 10.1177/00333549231192468.
Bowles J, Kolla G, Smith L, Scheim A, Dodd Z, Werb D
Drug Alcohol Depend Rep. 2023; 7:100167.
PMID: 37273749
PMC: 10199487.
DOI: 10.1016/j.dadr.2023.100167.
Factors associated with hospitalizations for co-occurring HIV and opioid-related diagnoses: Evidence from the national inpatient sample, 2009-2017.
Khodakarami N, Akinlotan M, Callaghan T, Primm K, Vadali M, Bolin J
Prev Med Rep. 2023; 34:102225.
PMID: 37214165
PMC: 10199244.
DOI: 10.1016/j.pmedr.2023.102225.
From crisis to crisis: impacts of the COVID-19 pandemic on people living with HIV and HIV/AIDS service organizations in Indiana.
MacNeill J, Linnes J, Hubach R, Rodriguez N
BMC Health Serv Res. 2022; 22(1):622.
PMID: 35534824
PMC: 9081957.
DOI: 10.1186/s12913-022-07998-0.
MHepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID.
Martel-Laferriere V, Feaster D, Metsch L, Schackman B, Loignon C, Nosyk B
Trials. 2022; 23(1):341.
PMID: 35461260
PMC: 9034074.
DOI: 10.1186/s13063-022-06085-3.
Drugs of Abuse and Their Impact on Viral Pathogenesis.
Blackard J, Sherman K
Viruses. 2021; 13(12).
PMID: 34960656
PMC: 8707190.
DOI: 10.3390/v13122387.
Injection and Non-Injection Drug Use Among Adults with Diagnosed HIV in the United States, 2015-2018.
Wu K, Tie Y, Dasgupta S, Beer L, Marcus R
AIDS Behav. 2021; 26(4):1026-1038.
PMID: 34536178
PMC: 8930780.
DOI: 10.1007/s10461-021-03457-9.
HIV Risk Among Urban and Suburban People Who Inject Drugs: Elevated Risk Among Fentanyl and Cocaine Injectors in Maryland.
Park J, Owczarzak J, Urquhart G, Morris M, Weicker N, Rouhani S
AIDS Behav. 2021; 26(1):277-283.
PMID: 34287755
PMC: 8294217.
DOI: 10.1007/s10461-021-03381-y.
Shifting the paradigm: physician-authorized, student-led efforts to provide harm reduction services amidst legislative opposition.
McMullen T, Naeim M, Newark C, Oliphant H, Suchard J, Banimahd F
Subst Abuse Treat Prev Policy. 2021; 16(1):27.
PMID: 33761954
PMC: 7992799.
DOI: 10.1186/s13011-021-00362-1.
Policing Practices and Risk of HIV Infection Among People Who Inject Drugs.
Baker P, Beletsky L, Avalos L, Venegas C, Rivera C, Strathdee S
Epidemiol Rev. 2020; 42(1):27-40.
PMID: 33184637
PMC: 7879596.
DOI: 10.1093/epirev/mxaa010.
Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities.
Krebs E, Zang X, Enns B, Min J, Behrends C, Del Rio C
J Infect Dis. 2020; 222(Suppl 5):S301-S311.
PMID: 32877548
PMC: 7566626.
DOI: 10.1093/infdis/jiaa130.
Opioid and neuroHIV Comorbidity - Current and Future Perspectives.
Fitting S, McRae M, Hauser K
J Neuroimmune Pharmacol. 2020; 15(4):584-627.
PMID: 32876803
PMC: 7463108.
DOI: 10.1007/s11481-020-09941-8.
Identification and characterization of tweets related to the 2015 Indiana HIV outbreak: A retrospective infoveillance study.
Cai M, Shah N, Li J, Chen W, Cuomo R, Obradovich N
PLoS One. 2020; 15(8):e0235150.
PMID: 32845882
PMC: 7449407.
DOI: 10.1371/journal.pone.0235150.
Competing forces of withdrawal and disease avoidance in the risk networks of people who inject drugs.
Ready E, Habecker P, Abadie R, Khan B, Dombrowski K
PLoS One. 2020; 15(6):e0235124.
PMID: 32569332
PMC: 7307734.
DOI: 10.1371/journal.pone.0235124.
Utilizing a Life Course Approach to Examine HIV Risk for Black Adolescent Girls and Young Adult Women in the United States: A Systematic Review of Recent Literature.
Taggart T, Milburn N, Nyhan K, Ritchwood T
Ethn Dis. 2020; 30(2):277-286.
PMID: 32346273
PMC: 7186047.
DOI: 10.18865/ed.30.2.277.
Impacts of mandated data collection on syringe distribution programs in the United States.
Davidson P, Chakrabarti P, Marquesen M
Int J Drug Policy. 2020; 79:102725.
PMID: 32259770
PMC: 7308185.
DOI: 10.1016/j.drugpo.2020.102725.
Syringe access and health harms: Characterizing "landscapes of antagonism" in California's Central Valley.
Syvertsen J, Pollini R
Int J Drug Policy. 2019; 75:102594.
PMID: 31775079
PMC: 7001150.
DOI: 10.1016/j.drugpo.2019.10.018.
